Afroz S. Mohammad

1.3k total citations
34 papers, 922 citations indexed

About

Afroz S. Mohammad is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Afroz S. Mohammad has authored 34 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Genetics and 12 papers in Oncology. Recurrent topics in Afroz S. Mohammad's work include Brain Metastases and Treatment (12 papers), Glioma Diagnosis and Treatment (12 papers) and Lung Cancer Research Studies (5 papers). Afroz S. Mohammad is often cited by papers focused on Brain Metastases and Treatment (12 papers), Glioma Diagnosis and Treatment (12 papers) and Lung Cancer Research Studies (5 papers). Afroz S. Mohammad collaborates with scholars based in United States, Egypt and Germany. Afroz S. Mohammad's co-authors include Paul R. Lockman, Chris E. Adkins, Werner J. Geldenhuys, Neal Shah, Jessica I. Griffith, Brandon Lucke‐Wold, Tori B. Terrell-Hall, Rajendar K. Mittapalli, William F. Elmquist and Mohamed Ismail Nounou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Afroz S. Mohammad

34 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Afroz S. Mohammad United States	16	315	312	294	204	162	34	922
Chris E. Adkins United States	19	578 1.8×	600 1.9×	401 1.4×	374 1.8×	315 1.9×	31	1.5k
Tae-Hee Lee South Korea	16	417 1.3×	191 0.6×	645 2.2×	190 0.9×	73 0.5×	62	1.4k
Bernhard Erdlenbruch Germany	18	175 0.6×	126 0.4×	448 1.5×	210 1.0×	46 0.3×	32	965
Youxin Zhou China	19	200 0.6×	88 0.3×	595 2.0×	165 0.8×	99 0.6×	60	1.1k
Qingchun Mu China	19	96 0.3×	77 0.2×	551 1.9×	124 0.6×	220 1.4×	48	1.1k
Danfeng Lin China	12	362 1.1×	219 0.7×	400 1.4×	25 0.1×	175 1.1×	18	1.1k
Andrew Kolozsvary United States	22	221 0.7×	284 0.9×	399 1.4×	217 1.1×	86 0.5×	28	1.1k
Huailei Liu China	22	73 0.2×	123 0.4×	645 2.2×	176 0.9×	124 0.8×	33	1.1k
Xuejiao Liu China	20	132 0.4×	87 0.3×	595 2.0×	160 0.8×	122 0.8×	40	938

Countries citing papers authored by Afroz S. Mohammad

Since Specialization

Citations

This map shows the geographic impact of Afroz S. Mohammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afroz S. Mohammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afroz S. Mohammad more than expected).

Fields of papers citing papers by Afroz S. Mohammad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afroz S. Mohammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afroz S. Mohammad. The network helps show where Afroz S. Mohammad may publish in the future.

Co-authorship network of co-authors of Afroz S. Mohammad

This figure shows the co-authorship network connecting the top 25 collaborators of Afroz S. Mohammad. A scholar is included among the top collaborators of Afroz S. Mohammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afroz S. Mohammad. Afroz S. Mohammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pang, Yinuo, Ronilda D’Cunha, Afroz S. Mohammad, et al.. (2023). Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease. Clinical Therapeutics. 46(1). 30–39. 5 indexed citations

Kenchappa, Rajappa S., Athanassios Dovas, Michael Argenziano, et al.. (2022). Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma. Cell Reports. 39(12). 110991–110991. 22 indexed citations

Talele, Surabhi, Wenjuan Zhang, Danielle M. Burgenske, et al.. (2021). Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma. Journal of Pharmacology and Experimental Therapeutics. 379(3). 343–357. 11 indexed citations

Liu, Zhongwei, Neal Shah, Samuel A. Sprowls, et al.. (2021). Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo. Archives of Toxicology. 95(11). 3575–3587. 7 indexed citations

Griffith, Jessica I., Minjee Kim, Daniel Bruce, et al.. (2021). Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity. Journal of Pharmacology and Experimental Therapeutics. 380(1). 34–46. 3 indexed citations

Steffen, Kristine J., Afroz S. Mohammad, James L. Roerig, et al.. (2021). Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical Controls. Obesity Surgery. 31(10). 4289–4294. 3 indexed citations

Kim, Minjee, Shiv K. Gupta, Wenjuan Zhang, et al.. (2021). Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor. Drug Metabolism and Disposition. 50(3). 277–286. 8 indexed citations

Gampa, Gautham, Rajappa S. Kenchappa, Afroz S. Mohammad, et al.. (2020). Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma. Scientific Reports. 10(1). 6524–6524. 21 indexed citations

Shah, Neal, Zhongwei Liu, Afroz S. Mohammad, et al.. (2020). Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis. BMC Cancer. 20(1). 292–292. 15 indexed citations

10.

Gampa, Gautham, Minjee Kim, Afroz S. Mohammad, et al.. (2019). Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases. Journal of Pharmacology and Experimental Therapeutics. 368(3). 446–461. 16 indexed citations

11.

Shah, Neal, Afroz S. Mohammad, Pushkar Saralkar, et al.. (2018). Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. Pharmacological Research. 132. 47–68. 105 indexed citations

12.

Mohammad, Afroz S., Jessica I. Griffith, Chris E. Adkins, et al.. (2018). Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer. Pharmaceutical Research. 35(2). 31–31. 54 indexed citations

13.

Mohammad, Afroz S., et al.. (2018). Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer. BMC Cancer. 18(1). 1225–1225. 13 indexed citations

14.

Lyle, L. Tiffany, Paul R. Lockman, Chris E. Adkins, et al.. (2016). Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clinical Cancer Research. 22(21). 5287–5299. 120 indexed citations

15.

Mittapalli, Rajendar K., Chris E. Adkins, Kaci A. Bohn, et al.. (2016). Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors. Cancer Research. 77(2). 238–246. 44 indexed citations

16.

Bohn, Kaci A., Chris E. Adkins, Rajendar K. Mittapalli, et al.. (2016). Semi-automated rapid quantification of brain vessel density utilizing fluorescent microscopy. Journal of Neuroscience Methods. 270. 124–131. 21 indexed citations

17.

Adkins, Chris E., Afroz S. Mohammad, Tori B. Terrell-Hall, et al.. (2016). Characterization of passive permeability at the blood–tumor barrier in five preclinical models of brain metastases of breast cancer. Clinical & Experimental Metastasis. 33(4). 373–383. 47 indexed citations

18.

Adkins, Chris E., Mohamed Ismail Nounou, Afroz S. Mohammad, et al.. (2015). NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer. BMC Cancer. 15(1). 685–685. 38 indexed citations

19.

Geldenhuys, Werner J., Afroz S. Mohammad, Chris E. Adkins, & Paul R. Lockman. (2015). Molecular Determinants of blood–brain Barrier Permeation. Therapeutic Delivery. 6(8). 961–971. 113 indexed citations

20.

Adkins, Chris E., Rajendar K. Mittapalli, Vamshi K. Manda, et al.. (2013). P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model. Frontiers in Pharmacology. 4. 136–136. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact